EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets

Binbin Tan iD, Jinxu Yang, Xibao Zhao, Shanshan Liu iD

International Journal of Molecular Sciences · 27.03.2026 · 27 (7) · 3065

DOI: 10.3390/ijms27073065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2026. Verfasst von Binbin Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Adenocarcinoma of Lung, Lung Neoplasms, Mitochondria. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Stable Support Project of Shenzhen, the Natural Science Foundation of Guangdong Province, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance is a major challenge in lung adenocarcinoma (LUAD) treatment and is associated with mitochondrial metabolism. Using publicly available LUAD transcriptome data, we established a five-gene prognostic signature (YWHAZ, HSPD1, NOTCH3, PGK1, and PPARG) for LUAD through differential gene expression profiling, univariate Cox analysis, and machine learning–based feature selection. Patients with LUAD were classified into a high-risk group (HRG) and a low-risk group (LRG) based on their risk scores. Enrichment analysis revealed significant differences between the HRG and LRG in multiple pathways related to metabolism and immunity. The immune microenvironment also differed significantly between the two groups, and the prognostic genes were correlated with infiltrating immune cells. A total of 110 compounds exhibited differential sensitivity across the groups. Molecular docking demonstrated a favorable binding affinity between the prognostic genes and the predicted drugs. Furthermore, YWHAZ knockdown significantly suppressed cancer cell proliferation in cell and animal models. In addition, YWHAZ knockdown markedly reduced cisplatin resistance by downregulating key regulators of the DNA replication and repair pathway, including POLA1 and MCM4. These results provide insight into the molecular mechanisms underlying chemoresistance and identify putative therapeutic targets for LUAD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmAdenocarcinoma of LungLung NeoplasmsMitochondriaHumansAnimalsGene Expression Regulation, NeoplasticPrognosisMolecular Docking SimulationCell Line, TumorGene Expression ProfilingMiceAntineoplastic AgentsTranscriptomeCell ProliferationCisplatin

Stichwörter der Autor:innen

chemoresistancelung adenocarcinomamitochondrial metabolismmolecular docking

Substanzen

Antineoplastic AgentsCisplatin

Autor:innen und Institutionen

  • Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China.

ORCID-Profile: Binbin Tan, Shanshan Liu

Förderung

  • the Stable Support Project of Shenzhen
  • the Natural Science Foundation of Guangdong Province
  • the National Natural Science Foundation of China

Zitieren

APA

Tan, B., Yang, J., Zhao, X., & Liu, S. (2026). Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets. International Journal of Molecular Sciences, 27(7), 3065. https://doi.org/10.3390/ijms27073065

Vancouver

Tan B, Yang J, Zhao X, Liu S. Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets. International Journal of Molecular Sciences. 2026;27(7):3065. doi:10.3390/ijms27073065

BibTeX
@article{Tan2026,
  author = {Tan, Binbin and Yang, Jinxu and Zhao, Xibao and Liu, Shanshan},
  title = {Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3065},
  doi = {10.3390/ijms27073065}
}
Kostenlos starten →